Christos M Chatzigiannis (Christos Chatzigiannis)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 7

Top Topics

Induced Apoptosis

Regulatory T Cells

Sentinel Lymph Node

Top Venues

Molecules (Basel, Switzerland)

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Natalija Jonić, Ivan Koprivica, Christos M Chatzigiannis, Antonis D Tsiailanis, Stavroula G Kyrkou, Eleftherios Paraskevas Tzakos, Aleksandar Pavic, Mirjana Dimitrijević, Andjelina Jovanović, Milan B Jovanović, Sérgio Marinho, Inês Castro-Almeida, Vesna Otasevic, Pedro Moura-Alves, Andreas G Tzakos, Ivana Stojanović
Development of FluoAHRL: A Novel Synthetic Fluorescent Compound That Activates AHR and Potentiates Anti-Inflammatory T Regulatory Cells. Molecules (Basel, Switzerland) 29 (13) (2024)
Natalija Jonić, Ivan Koprivica, Christos M Chatzigiannis, Antonis D Tsiailanis, Stavroula G Kyrkou, Eleftherios Paraskevas Tzakos, Aleksandar Pavic, Mirjana Dimitrijević, Andjelina Jovanović, Milan B Jovanović, Sérgio Marinho, Inês Castro-Almeida, Vesna Otasevic, Pedro Moura-Alves, Andreas G Tzakos, Ivana Stojanović
Development of FluoAHRL: A Novel Synthetic Fluorescent Compound That Activates AHR and Potentiates Anti-Inflammatory T Regulatory Cells. Molecules (Basel, Switzerland) 29 (13) (2024)
Natalija Jonić, Ivan Koprivica, Christos M Chatzigiannis, Antonis D Tsiailanis, Stavroula G Kyrkou, Eleftherios Paraskevas Tzakos, Aleksandar Pavic, Mirjana Dimitrijević, Andjelina Jovanović, Milan B Jovanović, Sérgio Marinho, Inês Castro-Almeida, Vesna Otasevic, Pedro Moura-Alves, Andreas G Tzakos, Ivana Stojanović
Development of FluoAHRL: A Novel Synthetic Fluorescent Compound That Activates AHR and Potentiates Anti-Inflammatory T Regulatory Cells. Molecules (Basel, Switzerland) 29 (13) (2024)
Antonios D Tsiailanis, Constantinos C Tellis, Paraskevi Papakyriakopoulou, Androniki D Kostagianni, Vasileios Gkalpinos, Christos M Chatzigiannis, Nikolaos G Kostomitsopoulos, Georgia Valsami, Alexandros D Tselepis, Andreas G Tzakos
Development of a Novel Apigenin Dosage form as a Substitute for the Modern Triple Antithrombotic Regimen. Molecules (Basel, Switzerland) 28 (5) (2023)
Antonios D Tsiailanis, Constantinos C Tellis, Paraskevi Papakyriakopoulou, Androniki D Kostagianni, Vasileios Gkalpinos, Christos M Chatzigiannis, Nikolaos G Kostomitsopoulos, Georgia Valsami, Alexandros D Tselepis, Andreas G Tzakos
Development of a Novel Apigenin Dosage form as a Substitute for the Modern Triple Antithrombotic Regimen. Molecules (Basel, Switzerland) 28 (5) (2023)
Antonios D Tsiailanis, Constantinos C Tellis, Paraskevi Papakyriakopoulou, Androniki D Kostagianni, Vasileios Gkalpinos, Christos M Chatzigiannis, Nikolaos G Kostomitsopoulos, Georgia Valsami, Alexandros D Tselepis, Andreas G Tzakos
Development of a Novel Apigenin Dosage form as a Substitute for the Modern Triple Antithrombotic Regimen. Molecules (Basel, Switzerland) 28 (5) (2023)
Alexander Renziehausen, Antonis D Tsiailanis, Richard Perryman, Evgenios Κ Stylos, Christos M Chatzigiannis, Kevin O'Neill, Timothy Crook, Andreas G Tzakos, Nelofer Syed
Encapsulation of Temozolomide in a Calixarene Nanocapsule Improves Its Stability and Enhances Its Therapeutic Efficacy against Glioblastoma. Molecular cancer therapeutics 18 (9) (2019)